Effect of mupirocin on nasal carriage of Staphylococcus aureus.
Mupirocin eliminates nasal carriage of Staphylococcus aureus among medical and surgical personnel for periods varying from several weeks up to one year. In persons recolonized after therapy densities of S. aureus populations in nares were much lower than in the same persons before therapy.
Bulanda
M
M
Department of Bacteriology, Medical Academy, Kraków, Poland.
Gruszka
M
M
Heczko
B
B
D000900:Anti-Bacterial Agents / Q000494:pharmacology* / Q000627:therapeutic use; D002353:Carrier State / Q000188:drug therapy / Q000382:microbiology*; D003428:Cross Infection / Q000517:prevention & control; D004311:Double-Blind Method; D005227:Fatty Acids / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D016712:Mupirocin; D009666:Nose / Q000382:microbiology*; D010564:Personnel, Hospital; D011044:Poland; D013203:Staphylococcal Infections / Q000188:drug therapy / Q000382:microbiology*
D000900:Anti-Bacterial Agents; D005227:Fatty Acids; D016712:Mupirocin